UPDATE: Jefferies Upgrades Express Scripts to Buy Following Elimination of Uncertainties

In a report published Monday, Jefferies analyst Brian Tanquilut upgraded the rating on Express Scripts Holding Company

from Hold to Buy, and raised the price target from $56.00 to $74.00. In the report, Tanquilut noted, “We are upgrading ESRX to Buy from Hold given our belief that the elimination of uncertainties surrounding member enrollment and contract attrition has cleared the tracks for ESRX's stock to outperform. The resumption of share repurchases, which takes advantage of ESRX's robust cash flows, should also enable the company to drive annual EPS growth of ~15%/year going forward and exceed current FY14 EPS expectations.” Express Scripts Holding Company closed on Friday at $61.40.